Dillion Merger Subsidiary Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Health
your username
6 days ago
A stockholder is suing Intec Pharma Ltd., Intec’s board of directors, and related entities over alleged violations of the Securities Exchange Act, per a Friday complaint filed in the District of Delaware regarding a proposed merger.
Plaintiff Craig Davidson is an owner of common stock of Intec, a biopharmaceutical company developing drug products based on its Accordion Pill platform that seeks to “improve the efficacy and safety” of drug products. On March 15, Intec’s board of directors executed a merger agreement with Intec Parent, Inc., Dillion Merger Subsidiary Inc., Domestication Merger Sub Ltd., and Decoy Biosystems Inc. The companies said in a news release that they are aiming for the merger to be executed in the third quarter of 2021, the complaint detailed. A registration statement with the Securities and Exchange Commission (SEC) followed on April 20. ....

United States , Craig Davidson , Exchange Commission , Intec Parent Inc , Dillion Merger Subsidiary Inc , Intec Pharma Ltd , Domestication Merger Sub Ltd , Securities Exchange , Decoy Biosystems Inc , Securities Exchange Act , Accordion Pill , Intec Parent , Decoy Biosystems , Registration Statement , ஒன்றுபட்டது மாநிலங்களில் , கிரேக் டேவிட்சன் , பரிமாற்றம் தரகு , ஈந்தெக் பார்மா லிமிடெட் , பத்திரங்கள் பரிமாற்றம் , சிதைவு உயிர் அமைப்புகள் இன்க் , பத்திரங்கள் பரிமாற்றம் நாடகம் , இசைக்கருவி வகை மாத்திரை , சிதைவு உயிர் அமைப்புகள் , பதிவு அறிக்கை ,